Logo

ENSG

The Ensign Group, Inc.

ENSG

The Ensign Group, Inc. NASDAQ
$185.54 -0.76% (-1.42)

Market Cap $10.67 B
52w High $194.00
52w Low $118.73
Dividend Yield 0.25%
P/E 33.25
Volume 104.93K
Outstanding Shares 57.52M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $1.296B $94M $83.844M 6.467% $1.46 $135.204M
Q2-2025 $1.228B $94.892M $84.396M 6.874% $1.48 $140.168M
Q1-2025 $1.173B $86.743M $80.277M 6.843% $1.41 $132.805M
Q4-2024 $1.132B $78.13M $79.687M 7.038% $1.4 $130.535M
Q3-2024 $1.082B $77.654M $78.444M 7.251% $1.38 $122.172M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $506.309M $5.226B $3.104B $2.119B
Q2-2025 $418.442M $4.93B $2.909B $2.018B
Q1-2025 $344.471M $4.76B $2.83B $1.927B
Q4-2024 $526.853M $4.669B $2.829B $1.837B
Q3-2024 $571.035M $4.629B $2.878B $1.747B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $83.911M $153M $-77.313M $4.012M $79.699M $101.807M
Q2-2025 $84.466M $155.73M $-68.12M $-6.307M $81.303M $106.135M
Q1-2025 $80.353M $72.22M $-243.804M $-10.348M $-181.932M $29.294M
Q4-2024 $79.75M $100.456M $-166.587M $-1.337M $-67.468M $52.295M
Q3-2024 $78.567M $134.481M $-78.901M $-850K $54.73M $89.037M

Revenue by Products

Product Q4-2024Q1-2025Q2-2025Q3-2025
Skilled Services Segment
Skilled Services Segment
$0 $0 $1.17Bn $1.24Bn
Standard Bearer Segment
Standard Bearer Segment
$0 $0 $30.00M $30.00M
Rental
Rental
$80.00M $30.00M $0 $0
Service
Service
$1.13Bn $1.17Bn $0 $0

Five-Year Company Overview

Income Statement

Income Statement Ensign’s income statement shows a business that has grown steadily and profitably over several years. Revenue has increased each year, and profits have generally risen along with it, suggesting that growth is not just coming from adding more facilities, but from running them efficiently. Operating margins and cash-style earnings look healthy, which points to good cost control in a labor‑intensive, heavily regulated sector. The recent step‑up in profit versus prior years stands out as a sign that scale and their operating model are working. The main risk to watch is that this is a reimbursement‑driven business, so changes in government pay rates or wage pressure could squeeze margins even if revenue keeps rising.


Balance Sheet

Balance Sheet The balance sheet reflects a company that has been expanding while strengthening its financial foundation. Total assets and shareholder equity have grown steadily, which means the business is building a larger, more substantial base of owned and controlled facilities. Debt has also increased over time, but it has grown alongside equity rather than racing ahead of it, suggesting a measured use of borrowing to fund expansion. Cash levels look comfortable for ongoing operations but not excessive, implying capital is mostly being put to work. The key watch point is that this model depends on continued disciplined use of leverage and maintaining solid coverage of interest and lease‑like obligations as the footprint grows.


Cash Flow

Cash Flow Ensign consistently generates positive cash flow from its operations, which is a strong sign that earnings are backed by real cash, not just accounting entries. Free cash flow has been positive each year as well, though it moves around a bit as the company steps up investment in new or improved facilities. Capital spending has been trending higher, which fits with an acquisitive, growth‑oriented strategy and their focus on controlling real estate. The trade‑off is that near‑term free cash flow can dip in years when they invest more heavily, so investors would want to see that these investments continue to translate into stronger earnings and cash generation down the road.


Competitive Edge

Competitive Edge Ensign occupies a strong niche in post‑acute and senior care, with a model that looks meaningfully different from many peers. Its decentralized “cluster” structure pushes decision‑making down to local leaders, who are financially motivated to improve both clinical and financial results. This can create faster, community‑specific responses than a traditional top‑down chain. The captive real estate arm adds another layer of advantage, giving the company more control over rent costs, facility improvements, and acquisitions of underperforming sites. On top of that, a broad mix of services—from skilled nursing and rehab to senior living, home health, hospice, and in‑house ancillary offerings—helps keep patients within their ecosystem. The flip side is exposure to regulatory shifts, labor shortages, and the operational complexity of managing many locations with considerable autonomy.


Innovation and R&D

Innovation and R&D Ensign’s “innovation” is mostly organizational and operational rather than traditional lab‑style research and development. The core idea is to empower local leadership, support them with a centralized service center, and use data analytics to track performance and share best practices quickly across the network. They also innovate in how they structure ownership and incentives, such as giving local teams a stake in their facility’s success. Technologically, they appear to rely on established software partners rather than home‑grown platforms, using data to manage census, mix of services, and profitability. Expansion into ancillary services, home health, and hospice shows a willingness to experiment with new offerings along the post‑acute care continuum. The main risk is that this kind of innovation is harder to protect than a patent; it depends on culture, leadership, and continuous execution.


Summary

Overall, Ensign looks like a scaled post‑acute care operator that has turned a distinctive operating model into steady growth and rising profitability. The financial statements point to a business that funds itself with solid operating cash flow, reinvests meaningfully in facilities and real estate, and uses debt in a relatively balanced way to support acquisitions. Its competitive edge rests more on culture, structure, and real estate control than on flashy technology, which has proven effective but must be continually maintained as the company grows. Key things to watch include reimbursement trends, labor costs, integration quality of new facilities, and whether their decentralized model and captive REIT continue to translate into better margins, stable cash flow, and resilient performance through industry cycles.